160
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Nicotinamide N-Methyl Transferase And Cancer-Associated Thrombosis: Insights To Prevention And Management

ORCID Icon, , &
Pages 385-395 | Received 01 Mar 2023, Accepted 24 Feb 2023, Published online: 22 May 2023

References

  • Bray F , FerlayJ , SoerjomataramIet al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394-424 (2018).
  • Yamashita S , KishinoT , TakahashiTet al. Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues. Proc. Natl Acad. Sci USA115(6), 1328-1333 (2018).
  • Parsons RB , SmithM-L , WilliamsAC , WaringRH , RamsdenDB. Expression of nicotinamide N-methyltransferase (EC 2.1. 1.1) in the Parkinsonian brain. J. Neuropathol. Exp. Neurol.61(2), 111-124 (2002).
  • Kulis M , EstellerM. DNA methylation and cancer. Adv. Genet.70, 27-56 (2010).
  • Hamidi T , SinghAK , ChenT. Genetic alterations of DNA methylation machinery in human diseases. Epigenomics7(2), 247-265 (2015).
  • Crispo F , CondelliV , LeporeSet al. Metabolic dysregulations and epigenetics: a bidirectional interplay that drives tumor progression. Cells8(8), 798 (2019).
  • Wong C , QianY , YuJ. Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches. Oncogene36(24), 3359-3374 (2017).
  • Kaushik AK , DeberardinisRJ. Applications of metabolomics to study cancer metabolism. Biochim. Biophys. Acta Rev. Cancer1870(1), 2-14 (2018).
  • Domblides C , LartigueL , FaustinB. Control of the antitumor immune response by cancer metabolism. Cells8(2), 104 (2019).
  • Hottiger MO . SnapShot: ADP-ribosylation signaling. Molec. Cell58(6), 1134-1134.e1131 (2015).
  • Undas A , BrozekJ , SzczeklikA. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb. Haemost.94(5), 907-915 (2005).
  • Falanga A , RussoL , MilesiV. The coagulopathy of cancer. Curr. Opin. Hematol.21(5), 423-429 (2014).
  • Ramsden DB , WaringRH , ParsonsRBet al. Nicotinamide N-methyltransferase: genomic connection to disease. Int. J. Tryptophan Res.13, 1178646920919770 (2020).
  • Aksoy S , BrandriffBF , WardAet al. Human nicotinamide N-methyltransferase gene: molecular cloning, structural characterization and chromosomal localization. Genomics29(3), 555-561 (1995).
  • Riederer M , ErwaW , ZimmermannRet al. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis204(2), 412-417 (2009).
  • De Jonge R , TissingWJ , HooijbergJHet al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood J. Am. Soc. Hematol.113(10), 2284-2289 (2009).
  • Koppen IJ , HermansFJ , KaspersGJ. Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br. J. Haematol.148(1), 3-14 (2010).
  • Roberg K , CederR , FarneboLet al. Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture. Differentiation76(8), 868-880 (2008).
  • Van Driel LM , SmedtsHP , HelbingWAet al. Eight-fold increased risk for congenital heart defects in children carrying the nicotinamide N-methyltransferase polymorphism and exposed to medicines and low nicotinamide. Eur. Heart J.29(11), 1424-1431 (2008).
  • Lu X , LongH. Nicotinamide N-methyltransferase as a potential marker for cancer. Neoplasma65(5), 656-663 (2018).
  • Roberti A , FernÆ€™¡ndezAF , FragaMF. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation. Mol. Metab.45, 101165 (2021).
  • Wilk A , HayatF , CunninghamRet al. Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity. Sci. Rep.10(1), 1-21 (2020).
  • Surjana D , HallidayGM , DamianDL. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J. Nucleic Acids2010, 157591 (2010).
  • Blot WJ , LiJ-Y , TaylorPRet al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. JNCI J. Natl. Cancer Inst.85(18), 1483-1491 (1993).
  • Morton JF . Maize and risk of cancers of the oral cavity, pharynx, and esophagus in northeastern Italy. J. Natl. Cancer Inst.83(2), 138-138 (1991).
  • Jacobson EL . Niacin deficiency and cancer in women. J. Am. Coll. Nutr.12(4), 412-416 (1993).
  • Lohani M , DhasmanaA , HaqueSet al. Niacin deficiency modulates genes involved in cancer: are smokers at higher risk? J. Cell. Biochem. 120(1), 232-242 (2019).
  • Inculet RI , NortonJA , NichoaldsGEet al. Water-soluble vitamins in cancer patients on parenteral nutrition: a prospective study. J. Parenter. Enteral Nutr.11(3), 243-249 (1987).
  • Dreizen S , MccredieKB , KeatingMJ , AnderssonBS. Nutritional deficiencies in patients receiving cancer chemotherapy. Postgrad. Med.87(1), 163-170 (1990).
  • Applegate L , LeyRD , AlcalayJ , KripkeML. Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J. Exp. Med.170(4), 1117-1131 (1989).
  • Park SM , LiT , WuSet al. Niacin intake and risk of skin cancer in US women and men. Int. J. Cancer140(9), 2023-2031 (2017).
  • Blazejczyk A , SwitalskaM , ChlopickiSet al. 1-methylnicotinamide and its structural analog 1, 4-dimethylpyridine for the prevention of cancer metastasis. J. Exp. Clin. Cancer Res.35(1), 1-13 (2016).
  • Swindall AF , StanleyJA , YangES. PARP-1: friend or foe of DNA damage and repair in tumorigenesis?Cancers5(3), 943-958 (2013).
  • VirÆ€™¡g L , SzabÆ€™³C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol. Rev.54(3), 375-429 (2002).
  • Mussbacher M , SalzmannM , BrostjanCet al. Cell type-specific roles of NF-Ã…½ºB linking inflammation and thrombosis. Front. Immunol.10, 85 (2019).
  • Anwar M , AslamHM , AnwarS. PARP inhibitors. Hered. Cancer Clin. Pract.13(1), 1-4 (2015).
  • Nakajima TE , YamadaY , HamanoTet al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J. Gastroenterol.44(7), 685-690 (2009).
  • Sartini D , SetaR , PozziVet al. Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity. Biol. Chem.396(3), 225-234 (2015).
  • Wang Y , ZengJ , WuWet al. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Breast Cancer Res.21(1), 1-17 (2019).
  • Kim J , HongSJ , LimEKet al. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. J. Exp. Clin. Cancer Res.28(1), 1-9 (2009).
  • Song M , LiY , MiaoMet al. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer. Cancer Med.9(6), 2030-2038 (2020).
  • Hsu C-N , LaiJ-M , LiuC-Het al. Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinform.8(1), 1-12 (2007).
  • Xie X , LiuH , WangYet al. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway. Oncotarget7(29), 45837 (2016).
  • Hsu S , KimM , HernandezLet al. IKK-ϵ coordinates invasion and metastasis of ovarian cancer. Cancer Res.72(21), 5494-5504 (2012).
  • Tateno C , KataokaM , UtohRet al. Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Endocrinology152(4), 1479-1491 (2011).
  • Nabokikh A , IlhanA , BilbanMet al. Reduced TGF-Æ€™Ãƒ€¦¸1 expression and its target genes in human insulinomas. Exp. Clin. Endocrinol. Diabetes115(10), 674-682 (2007).
  • Xu J , CapezzoneM , XuX , HershmanJM. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1Ã…½² in human papillary thyroid cancer cells. Mol. Endocrinol.19(2), 527-539 (2005).
  • Heemers HV , SchmidtLJ , SunZet al. Identification of a clinically relevant androgen-dependent gene signature in prostate cancerclinically relevant mechanism of androgen action in prostate cancer. Cancer Res.71(5), 1978-1988 (2011).
  • Cui Y , ZhangL , WangWet al. Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/Ã…½²-catenin pathway. Mol. Cellular Biochem.460(1), 93-103 (2019).
  • Shin JH , ParkCW , YoonGet al. NNMT depletion contributes to liver cancer cell survival by enhancing autophagy under nutrient starvation. Oncogenesis7(8), 1-14 (2018).
  • Zhang J , WangY , LiGet al. Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway. PLOS ONE9(2), e89202 (2014).
  • Pozzi V , MazzottaM , MuzioLLet al. Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Int. J. Immunopathol. Pharmacol.24(1), 69-77 (2011).
  • Huang M , ZhangD , WuJYet al. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Sci. Trans. Med.12(532), eaay7522 (2020).
  • Jung J , KimLJ , WangXet al. Nicotinamide metabolism regulates glioblastoma stem cell maintenance. JCI Insight2(10), e90019 (2017).
  • Dudas JLA , IngruberJ , SteinbichlerTB , RiechelmannH. Epithelial to mesenchymal transition: a mechanism that fuels cancer radio/chemoresistance. Cellsdoi:10.3390/cells9020428 (2020).
  • Mudd SH , BrosnanJT , BrosnanMEet al. Methyl balance and transmethylation fluxes in humans. Am. J. Clin. Nutr.85(1), 19-25 (2007).
  • Takeshima H , UshijimaT. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. NPJ Precision Oncol.3(1), 7 (2019).
  • Zaorsky NG , ChurillaT , EglestonBet al. Causes of death among cancer patients. Ann. Oncol.28(2), 400-407 (2017).
  • Raskob GE , AngchaisuksiriP , BlancoANet al. Thrombosis: a major contributor to global disease burden. Arterioscler. Thromb. Vasc. Biol.34(11), 2363-2371 (2014).
  • Fernandes CJ , MorinagaLTK , AlvesJLJet al. Cancer-associated thrombosis: the when, how and why. Eur. Respir. Rev.28(151), 180119 (2019).
  • Abdol Razak NB , JonesG , BhandariMet al. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers10(10), 380 (2018).
  • Fuentes HE , TafurAJ , CapriniJA. Cancer-associated thrombosis. Disease-a-Month5(62), 121-158 (2016).
  • Keita I , Aubin-AugerI , LalanneCet al. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism. Patient Prefer. Adherence11, 1625 (2017).
  • Meikle CK , KellyCA , GargPet al. Cancer and thrombosis: the platelet perspective. Front. Cell Dev. Biol.4, 147 (2017).
  • Dunbar A , BoltonKL , DevlinSMet al. Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors. Blood137(15), 2103-2113 (2021).
  • Shi YH , FangWG. Hypoxia-inducible factor-1 in tumour angiogenesis. World J. Gastroenterol.10(8), 1082-1087 (2004).
  • Man S , SanchezDuffhues G , TenDijke P , BakerD. The therapeutic potential of targeting the endothelial-to-mesenchymal transition. Angiogenesis22(1), 3-13 (2019).
  • Friedl P , WolfK. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer3(5), 362-374 (2003).
  • Poggi A , StellaM , DonatiMB. 10 The importance of blood cell-vessel wall interactions in tumour metastasis. BailliÆ€™¨re Clin. Haematol.6(3), 731-752 (1993).
  • Falanga A , MarchettiM. Anticancer treatment and thrombosis. Thromb. Res.129(3), 353-359 (2012).
  • Goldenberg N , KahnSR , SolymossS. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J. Clin. Oncol.21(22), 4194-4199 (2003).
  • Semenza GL , JiangBH , LeungSWet al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem.271(51), 32529-32537 (1996).
  • Semenza GL . HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol.doi:10.1152/jappl.2000.88.4.14741474-1480 (2000).
  • Ryan HE , LoJ , JohnsonRS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J.17(11), 3005-3015 (1998).
  • Tobu M , IqbalO , FareedDet al. Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor. Clin. Appl. Thromb Hemost.10(3), 225-232 (2004).
  • Davila M , AmirkhosraviA , CollEet al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J. Thromb. Haemost.6(9), 1517-1524 (2008).
  • Nadir Y , BrennerB. Heparanase multiple effects in cancer. Thromb. Res.133, S90-S94 (2014).
  • Vormittag R , SimanekR , AyCet al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb. Vasc. Biol.29(12), 2176-2181 (2009).
  • AndrÆ€™©n-Sandberg Æ€™€š¬¦ , LecanderI , MartinssonG , Æ€™€š¬¦stedtB. Peaks in plasma plasminogen activator inhibitor-1 concentration may explain thrombotic events in cases of pancreatic carcinoma. Cancer69(12), 2884-2887 (1992).
  • Sciacca FL , CiusaniE , SilvaniAet al. Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin. Cancer Res.10(4), 1312-1317 (2004).
  • Sauls D , WolbergA , HoffmanM. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia. J. Thromb. Haemost.1(2), 300-306 (2003).
  • Ma Y , PengD , LiuCet al. Serum high concentrations of homocysteine and low levels of folic acid and vitamin B(12) are significantly correlated with the categories of coronary artery diseases. BMC Cardiovasc. Disord.17(1), 37 (2017).
  • Shi Z , LiuS , GuanYet al. Changes in total homocysteine levels after acute stroke and recurrence of stroke. Sci. Rep.8(1), 1-6 (2018).
  • Zhang D , WenX , WuWet al. Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals. PLoS One10(5), e0123423 (2015).
  • BravatÆ€™  V . Controversial roles of methylenetetrahydrofolate reductase polymorphisms and folate in breast cancer disease. Int. J. Food Sci. Nutr.66(1), 43-49 (2015).
  • Esposito E , AldreesS , MastromonacoCet al. AvaliaÆ€™§Ã†€™£o da nicotinamida como agente anti-inflamatÆ€™³rio e anti-angiogÆ€™ªnico em linhas celulares de melanoma uveal. Arquivos Brasileiros Oftalmol.80(2), 74-77 (2017).
  • Itzhaki O , GreenbergE , ShalmonBet al. Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma. PLOS ONE8(2), e57160 (2013).
  • Elshorbagy A , JernerÆ€™©nF , Samocha-BonetDet al. Serum S-adenosylmethionine, but not methionine, increases in response to overfeeding in humans. Nutr. Diabetes6(1), e192-e192 (2016).
  • Loehrer FM , AngstCP , HaefeliWEet al. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease. Arterioscler. Thromb. Vasc. Biol.16(6), 727-733 (1996).
  • De La Cruz J , MÆ€™©ridaM , GonzÆ€™¡lez-CorreaJet al. Effects of S-adenosyl-L-methionine on blood platelet activation. Gen. Pharmacol. Vasc. Syst.29(4), 651-655 (1997).
  • Thompson MA , BauerBA , LoehrerLLet al. Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial. J. Altern. Complement. Med.15(5), 523 (2009).
  • Sperber H , MathieuJ , WangYet al. The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat. Cell Biol.17(12), 1523-1535 (2015).
  • Xu J , HershmanJM. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1 Ã…½² gene expression in human papillary thyroid cancer cells. Thyroid16(2), 151-160 (2006).
  • Kwon A , JeonS-M , HwangS-Het al. Expression and functional role of metallothioneins I and II in the spinal cord in inflammatory and neuropathic pain models. Brain Res.1523, 37-48 (2013).
  • Chlopicki S , SwiesJ , MogielnickiAet al. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br. J. Pharmacol.152(2), 230-239 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.